Celltrion
068270.KS
#754
Rank
HK$209.14 B
Marketcap
HK$1,010
Share price
0.72%
Change (1 day)
7.06%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Net assets

Net assets on the balance sheet as of June 2024 : HK$95.71 Billion

According to Celltrion 's latest financial reports the company has HK$95.71 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Celltrion - Net assets on balance sheet (from 2007 to 2024)

Net assets by year

Year Net assets Change
2022-12-31$HK$26.48 B-0.22%
2021-12-31$HK$26.54 B8.53%
2020-12-31$HK$24.45 B26.4%
2019-12-31$HK$19.34 B6.28%
2018-12-31$HK$18.20 B3.06%
2017-12-31$HK$17.66 B33.25%
2016-12-31$HK$13.25 B18.08%
2015-12-31$HK$11.22 B17.64%
2014-12-31$HK$9.54 B19.37%
2013-12-31$HK$7.99 B1.97%
2012-12-31$HK$7.84 B30.12%
2011-12-31$HK$6.02 B11.91%
2010-12-31$HK$5.38 B179.84%
2009-12-31$HK$1.92 B40.78%
2008-12-31$HK$1.36 B510.73%
2007-12-31$HK$0.22 B